RG
NTUS

Renaissance Group’s Natus Medical Inc NTUS Stock Holding History

Renaissance Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,534
Closed -$296K – 293
2017
Q1 		$296K Sell
7,534
-189
-2% -$7.09K 0.01% 252
2016
Q4 		$269K Buy
+7,723
New +$303K 0.01% 254

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Renaissance Group's NTUS Position: Q2 2017 in Review

Renaissance Group sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 7,534 shares — an estimated $296K sold.

Renaissance Group first reported a position in NTUS in Q4 2016 and held it in 2 quarters. The position peaked at $296K in Q1 2017. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

  • Renaissance Group reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
  • Renaissance Group sold 7,534 Natus Medical Inc shares in Q2 2017, an estimated $296K.
  • Renaissance Group first reported a position in Natus Medical Inc in Q4 2016 and held it in 2 quarters.
  • Renaissance Group's Natus Medical Inc position peaked at $296K in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Renaissance Group's 13F filing for Q2 2017, filed 8 Aug 2017.